AVTR
NYSEAvantor Inc.
Price$8.09+0.24 (+3.06%)
01:30 PM07:45 PM
News · 26 weeks57+14%
2025-11-022026-04-26
Mix3690d
- Insider17(47%)
- SEC Filings10(28%)
- Other5(14%)
- Earnings3(8%)
- Analyst1(3%)
Latest news
25 items- SECSEC Form 10-Q filed by Avantor Inc.10-Q - Avantor, Inc. (0001722482) (Filer)
- SECAvantor Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Avantor, Inc. (0001722482) (Filer)
- PRAvantor® Reports First Quarter 2026 ResultsNet sales of $1,581 millionNet income of $43 million; Adjusted EBITDA of $219 millionDiluted GAAP EPS of $0.06; adjusted EPS of $0.17Operating cash flow of $59 million; free cash flow of $25 millionReaffirms FY 2026 guidanceRADNOR, Pa., April 29, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first fiscal quarter ended March 31, 2026."First quarter results exceeded our expectations due to improved execution in Bioscience and Medtech Products, and we saw stabilization in VWR," said Emmanuel Ligner, President and Chi
- SECAvantor Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Avantor, Inc. (0001722482) (Filer)
- PRAvantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation OfficerRADNOR, Pa., April 23, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Ludovic Brellier will join the company as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer on May 1, 2026. In this role, Mr. Brellier will be responsible for growing the BMP business and improving operational performance. He will also lead the Revival Management Office, driving transformation initiatives acros
- PRAvantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess ManufacturingPortfolio now includes standard, configurable, and engineered-to-order peristaltic pumps, single-use assemblies, and systems for R&D through high-volume manufacturingCompany to attend INTERPHEX 2026 in New York City from April 21-23RADNOR, Pa., April 21, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to the life sciences and advanced technology industries, today announced the expansion of its Masterflex brand across its fluid handling portfolio, bringing together standard, configurable, and engineered-to-order peristaltic pumps, single-use assemblies, and systems.
- PRAvantor® Enhances U.S. Biomanufacturing Infrastructure with Expanded Stability and Microbial Testing FacilitySt. Louis site strengthens integrated support for biopharma manufacturingRADNOR, Pa., April 13, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the expansion of its North American quality control capabilities with the addition of advanced microbial and stability testing at its St. Louis manufacturing site. The investment builds on Avantor's established global quality infrastructure, expanding and localizing capabilities to better sup
- INSIDERSEC Form 4 filed by Eck Steven W4 - Avantor, Inc. (0001722482) (Issuer)
- PRAvantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026RADNOR, Pa., April 3, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2026 financial results before the market opens on Wednesday, April 29, and will hold a conference call to discuss the results on the same day at 8:00 a.m. Eastern Daylight Time. To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com. A repl
- SECAvantor Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Avantor, Inc. (0001722482) (Filer)
- PRAvantor® Announces CFO TransitionRADNOR, Pa., April 1, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Executive Vice President and Chief Financial Officer (CFO), R. Brent Jones, will leave the Company on or before June 24, 2026. Avantor has initiated a search to identify the Company's next CFO. To ensure a smooth transition until a new CFO is appointed, Steve Eck, Senior Vice President and Chief Accounting Officer (CAO), will serve as interim CFO upon Mr
- SECSEC Form DEFA14A filed by Avantor Inc.DEFA14A - Avantor, Inc. (0001722482) (Filer)
- SECSEC Form DEF 14A filed by Avantor Inc.DEF 14A - Avantor, Inc. (0001722482) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Avantor Inc.SCHEDULE 13G/A - Avantor, Inc. (0001722482) (Subject)
- INSIDERSEC Form 4 filed by Avantor Inc.4 - Avantor, Inc. (0001722482) (Issuer)
- ANALYSTAvantor downgraded by Barclays with a new price targetBarclays downgraded Avantor from Equal Weight to Underweight and set a new price target of $8.50
- INSIDEREVP, Chief Legal & Compliance Sokenu Claudius covered exercise/tax liability with 2,376 shares, decreasing direct ownership by 0.93% to 252,429 units (SEC Form 4)4 - Avantor, Inc. (0001722482) (Issuer)
- INSIDEREVP, Chief HR Officer Hankamer Brittany covered exercise/tax liability with 1,683 shares, decreasing direct ownership by 0.67% to 249,045 units (SEC Form 4)4 - Avantor, Inc. (0001722482) (Issuer)
- INSIDEREVP, Chief Financial Officer Jones R. Brent covered exercise/tax liability with 2,805 shares, decreasing direct ownership by 0.66% to 419,782 units (SEC Form 4)4 - Avantor, Inc. (0001722482) (Issuer)
- INSIDERSVP & Chief Accounting Officer Eck Steven W covered exercise/tax liability with 2,469 shares, decreasing direct ownership by 2% to 99,333 units (SEC Form 4)4 - Avantor, Inc. (0001722482) (Issuer)
- INSIDEREVP, Bioscience & Medtech Gourdier Benoit covered exercise/tax liability with 3,029 shares, decreasing direct ownership by 0.83% to 362,859 units (SEC Form 4)4 - Avantor, Inc. (0001722482) (Issuer)
- SECAmendment: Avantor Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K/A - Avantor, Inc. (0001722482) (Filer)
- SECAmendment: Avantor Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K/A - Avantor, Inc. (0001722482) (Filer)
- INSIDEREVP, Chief Operating Officer Blenn Mary was granted 235,993 shares, increasing direct ownership by 1,357% to 253,384 units (SEC Form 4)4 - Avantor, Inc. (0001722482) (Issuer)
- INSIDERDirector Lucier Gregory T bought $458,000 worth of shares (50,000 units at $9.16) (SEC Form 4)4 - Avantor, Inc. (0001722482) (Issuer)
AVTR FAQ
7 questionsWhat does Avantor Inc. do?
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and...Where does AVTR stock trade?
Avantor Inc. (AVTR) is listed on NYSE.What sector and industry is AVTR in?
Avantor Inc. operates in the Industrials sector, Biotechnology: Laboratory Analytical Instruments industry.When did Avantor Inc. go public?
Avantor Inc. (AVTR) completed its IPO in 2019.What are analysts saying about AVTR?
Avantor Inc. has had 8 recent analyst actions on file. The most recent action was from Barclays: Underweight with a $850.00 price target on 2026-03-06. Recent price targets range from $850.00 to $1300.00.What companies are similar to AVTR?
Notable peers in the same industry include A (Agilent Technologies Inc.), WAT (Waters Corporation), MTD (Mettler-Toledo International Inc.), PKI (PerkinElmer Inc.), RVTY (Revvity Inc.). Compare AVTR side-by-side with any of them on Quantisnow.How can I track AVTR on Quantisnow?
Quantisnow aggregates Avantor Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AVTR to receive live email and push alerts on every new disclosure.